In contrast, overweight, obesity, increased lipogenesis, and hepatic steatosis exacerbate SHBG synthesis inhibitory factors (e.g., chicken ovalbumin upstream promoter transcription factor (COUP-TF) or peroxisome proliferator-activated receptor gamma (PPARγ)) [24]. Here, PPARG is linked to fatty liver disease.